Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice

Neuropharmacology

Volumn 54, Issue 7, 2008, Pages 1107-1111

  Marie Claire, Cynthia ^a   Palminteri, Stefano ^b   Romualdi, Patrizia ^b   Noble, Florence ^a  

^a CNRS   (France)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Behavior; Gene expression; MDMA; Mice; Neurotensin

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; NEUROTENSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG INHIBITION; GENE EXPRESSION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

3,4-METHYLENEDIOXYAMPHETAMINE; ADAMANTANE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; CORPUS STRIATUM; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; HALLUCINOGENS; IMIDAZOLES; MALE; MICE; MOTOR ACTIVITY; NEUROTENSIN; RECEPTORS, NEUROTENSIN; TIME FACTORS;

EID: 42749095083     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.03.001     Document Type: Article

References (24)

1. Azmi N., Norman C., Spicer C., and Bennett G. Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task. Behavioural Pharmacology 17 (2006) 357-362
2. Battaglia G., Brooks B.P., Kulsakdinun C., and De Souza E.B. Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. European Journal of Pharmacology 149 (1988) 159-163
3. Berger B., Gaspar P., and Verney C. Colocalization of neurotensin in the mesocortical dopaminergic system. Restricted regional and laminar distribution in rat, lack of colocalization in human. Annals of the New York Academy of Sciences 668 (1992) 307-310
4. Betancur C., Cabrera R., de Kloet E.R., Pelaprat D., and Rostene W. Role of endogenous neurotensin in the behavioral and neuroendocrine effects of cocaine. Neuropsychopharmacology 19 (1998) 322-332
5. Binder E., Gross R., Nemeroff C., and Kilts C. Effects of neurotensin receptor antagonism on latent inhibition in Sprague-Dawley rats. Psychopharmacology 161 (2002) 288-295
6. Cervo L., and Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Research 673 (1995) 242-250
7. Colado M.I., O'Shea E., and Green A.R. Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology (Berl) 173 (2004) 249-263
8. Fenu S., Spina L., Rivas E., Longoni R., and Di Chiara G. Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression. Psychopharmacology 187 (2006) 143-153
9. Ferraro L., O'Connor W.T., Antonelli T., Fuxe K., and Tanganelli S. Differential effects of intrastriatal neurotensin (1-13) and neurotensin (8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat. European Journal of Neuroscience 9 (1997) 1838-1846
10. Garris P.A., Kilpatrick M., Bunin M.A., Michael D., Walker Q.D., and Wightman R.M. Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature 398 (1999) 67-69
11. Geisler S., Berod A., Zahm D.S., and Rostene W. Brain neurotensin, psychostimulants, and stress - emphasis on neuroanatomical substrates. Peptides 27 (2006) 2364-2384
12. Harris G.C., Wimmer M., Byrne R., and Aston-Jones G. Glutamate-associated plasticity in the ventral tegmental area is necessary for conditioning environmental stimuli with morphine. Neuroscience 129 (2004) 841-847
13. Hokfelt T., Everitt B., Theodorsson-Norheim E., and Goldstein M. Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. The Journal of Comparative Neurology 222 (1984) 543-559
14. Horger B., Taylor J., Elsworth J., and Roth R. Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology 11 (1994) 215-222
15. Nieto M.M., Wilson J., Cupo A., Roques B.P., and Noble F. Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. Journal of Neuroscience 22 (2002) 1034-1041
16. Panayi F., Dorso E., Lambás-Señas L., Renaud B., Scarna H., and Berod A. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to d-amphetamine. Neuropsychopharmacology 26 (2002) 64-74
17. Panayi F., Colussi-Mas J., Lambás-Señas L., Renaud B., Scarna H., and Berod A. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization. Neuropsychopharmacology 30 (2005) 871-879
18. Paxinos G., and Franklin K. The Mouse Brain in Stereotaxic Coordinates (2000), Academic Press
19. Rompre P.-P., and Perron S. Evidence for a role of endogenous neurotensin in the initiation of amphetamine sensitization. Neuropharmacology 39 (2000) 1880-1892
20. Salzmann J., Marie-Claire C., Le Guen S., Roques B.P., and Noble F. Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. British Journal of Pharmacology 140 (2003) 831-838
21. Salzmann J., Canestrelli C., Noble F., and Marie-Claire C. Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes. Neuroscience 137 (2006) 473-482
22. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 275 (1997) 1593-1599
23. Sellings L.H.L., and Clarke P.B.S. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. Journal of Neuroscience 23 (2003) 6295-6303
24. Trigo J., Panayi F., Soria G., Maldonado R., and Robledo P. A reliable model of intravenous MDMA self-administration in naïve mice. Psychopharmacology 184 (2006) 212-220